THERAPEUTIC CLASS

A new medical therapy for anemia in thalassemia

---

In this issue of Blood, Piga et al report results of a phase 2, open label, nonrandomized, uncontrolled dose-finding study evaluating the effects of luspatercept on erythroid maturation and differentiation in adult patients with b-thalassemia.1 A high percentage of patients had an increase in hemoglobin or a reduction in transfusion burden, which helped lay the basis for
future randomized trials

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Cardiovascular & Hematopoietic System

Specific Detail Info

Blood 2019;133(12):1267-1269

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment